Navigation Links
Scientists advance safety of nanotechnology
Date:6/10/2009

was developed by German scientists in 1984. Nanomaterials are now used in a variety of products, including sporting goods, cosmetics and electronics. The fact that unusual physical, chemical, and biological properties can emerge in materials at the nanoscale makes them particularly appealing for medicine. Scientists hope nanoparticles will be able to improve the effectiveness of drugs and gene therapy by carrying them to the right place in the body and by targeting specific tissues, regulating the release of drugs and reducing damage to healthy tissues. They also envision the possibility of implantable nano devices that would detect disease, treat it and report to the doctor automatically from inside the body. The US Food and Drug Administration has approved some first generation nanodrugs. One example is Abraxane, a nanoformulation of the anti-cancer chemotherapy paclitaxel.

Lung damage is the chief human toxicity concern surrounding nanotechnology, with studies showing that most nanoparticles migrate to the lungs. However, there are also worries over the potential for damage to other organs.

In the study, the researchers first showed, through several independent experiments, that several types of PAMAMs killed human lung cells in the lab. They did not observe any evidence that the cells were dying by apoptosis, a common type of programmed cell death. However, they found that the particles triggered autophagic cell death through the Akt-TSC2-mTOR signalling pathway. Autophagy is a process that degrades damaged materials in a cell and plays a normal part in cell growth and renewal, but scientists have found that sometimes an overactivity of this destruction process leads to cell death.

The researchers also found that treating the cells with an autophagy inhibitor known as 3MA significantly inhibited the process, increasing the number of cells that survived exposure to the nanoparticles.


'/>"/>
Contact: Emma Ross
rosswrite@mac.com
Oxford University Press
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related medicine news :

1. UNC scientists identify growth factor as possible cancer drug target
2. World first: Chinese scientists create pig stem cells
3. Scientists use bed bugs own chemistry against them
4. NYP/Weill Cornell physician-scientists present at 2009 American Transplant Congress in Boston
5. Scripps Florida scientists devise accelerated method to determine infectious prion strains
6. Scientists find city rats are loyal to their hoods
7. Scientists find shared genetic link between the dental disease periodontitis and heart attack
8. Photos: The Nations Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research
9. Scientists develop mathematical model to predict the immune response to influenza
10. Americas Top Young Scientists to Receive Scholarships for Winning Eggs-Periments
11. Scientists identify gene in breast cancer pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Food and Health Bureau has invited expressions of interest ... private hospitals at four sites in the Hong Kong ... March 31, 2010. ,, At a press conference, ... said the promotion of private hospital development was one ... Hong Kong government policy announced by Chief Executive Donald ...
(Date:12/15/2009)... Lupus Foundation of America and the Saint Thomas, Lupus ... Julian Lennon, son of the legendary John Lennon, and ... "LUCY," to raise funds for research on the disease ... of the proceeds from downloading "LUCY" at iTunes will ... and the Saint Thomas, Lupus Trust in Great Britain. ...
(Date:12/15/2009)... where all couples of reproductive age were evaluated, Italian ... The number of children born with cystic fibrosis decreases ... mutation carriers increases, a new study finds. , CF ... northeast Italy for many years. Since the 1990s, the ... number of infants born with CF. , Two different ...
(Date:12/15/2009)... needed for protection, CDC says, , , TUESDAY, Dec. 15 ... swine flu vaccine have been recalled by manufacturer Sanofi ... health officials said Tuesday. , According to the U.S. ... testing of the vaccine for children aged 6 months ... lower than required potency levels. "This means that doses ...
(Date:12/15/2009)... to be leaders in the fight against malaria ... experts in online learning, the Masie Center and ... -- ONE and Malaria No More ... first-ever "Malaria Griots" program, a dynamic education course ... leaders in the fight against malaria. ,, ...
Breaking Medicine News(10 mins):Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4
... Mass. - A new paper published in the latest ... Medical Internet Research evaluates consumers, experiences with the ... system developed by researchers in the Children,s Hospital Informatics ... been adapted by PCHR providers including Dossia, Microsoft and ...
... source of outbreak -- reports leveling off of cases , , ... swine flu cases in the United States has surpassed 100, ... be mild. , In response to the outbreak, scientists are ... never-before-seen flu strain, but the shots -- if needed at ...
... The Female Health Company (NYSE Amex: FHC ) ... to discuss its operating results for the second quarter and ... on Friday, May 8, 2009. The Company expects to ... results earlier the same day. Shareholders and other interested parties ...
... Pharmaceuticals International (NYSE: VRX ) today announced members ... the Bank of America and Merrill Lynch 2009 Health Care ... The conference will be held at The Palace Hotel in ... presentation will be available on the company,s Web site at ...
... -- Three Roche employees were recognized ... Jersey at the 2009 TWIN Awards Dinner held ... J.D., senior counsel and managing attorney; Theresa Martinez, ... Pegasys(R) (peginterferon alfa-2a); and Linda Lee-Mathieson, Director, Clinical ...
... Gaiam, Inc. (Nasdaq: GAIA ), a ... and services to customers who value personal development, wellness, ... results for the first quarter ended March 31, 2009 ... 2009. The Company will hold a teleconference to discuss ...
Other Medicine News:Health News:New study evaluates community response to personally controlled health information 2Health News:New study evaluates community response to personally controlled health information 3Health News:Swine Flu Infections Near 110 in U.S. 2Health News:Swine Flu Infections Near 110 in U.S. 3Health News:Swine Flu Infections Near 110 in U.S. 4Health News:Swine Flu Infections Near 110 in U.S. 5Health News:Swine Flu Infections Near 110 in U.S. 6Health News:Swine Flu Infections Near 110 in U.S. 7Health News:The Female Health Company Schedules Second Quarter Conference Call for May 8, 2009 2Health News:Valeant Pharmaceuticals to Present at Bank of America and Merrill Lynch 2009 Health Care Conference 2Health News:Roche Women Honored as 2009 TWIN Awardees 2Health News:Roche Women Honored as 2009 TWIN Awardees 3Health News:Roche Women Honored as 2009 TWIN Awardees 4Health News:Roche Women Honored as 2009 TWIN Awardees 5
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) today announced that ... notice (the "Notice") executed by the Marc S. Hermelin ... requesting that the Board of Directors of the Company ... by written consent relating to the proposed appointment of ... from Ronald J. Kanterman,s departure (the "Director Appointment"). ,, ...
(Date:12/15/2009)... Inc. and Alzheimer,s Weekly today announced the winners of ... designed to help five seniors in their fight to ... five winners will receive a $2,500 Dakim BrainFitness System, ... their brain health and the most widely adopted product ... country. ,, The contest, held to coincide ...
(Date:12/15/2009)... 15 A Harvard medical expert internationally recognized ... the PGA Tour,s decision last month to suspend ... diagnosed him as having the medical condition ... condition is "unreasonable, unfair and discriminatory." ,, ... normal testosterone levels, often referred to informally as ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 75 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest 4788 1Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest 4788 2Updated CDC Travel Health Book Released 52968 1Updated CDC Travel Health Book Released 52968 2Updated CDC Travel Health Book Released 52968 3Study 3A Being active as a preschooler pays off later in childhood 52963 1Study 3A Being active as a preschooler pays off later in childhood 52963 2
... Inc. today announced the presentation of several,scientific studies ... the Annual Meeting of the American Association for ... Los Angeles,California. During this meeting, on Sunday, April ... Onconova was honored as,the recipient of the 2006-2007 ...
... Calif.--(BUSINESS WIRE)--Apr 16, 2007 - Amgen,(Nasdaq:AMGN) today presented ... study evaluating the,efficacy and safety of Aranesp(R) (darbepoetin ... active cancer not receiving,chemotherapy or radiotherapy ("the 103 ... FDA or EMEA in these patients. These,results were ...
Other Medicine Technology:Onconova Therapeutics Announces Presentation of Clinical and,Non-Clinical Results for Its Lead Compound ON 01910.Na at American,Association of Cancer Research Conference in Los Angeles 2Onconova Therapeutics Announces Presentation of Clinical and,Non-Clinical Results for Its Lead Compound ON 01910.Na at American,Association of Cancer Research Conference in Los Angeles 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7
Inquire...
... Vibratome Roto-Shake Genie is an all-in-one ... It performs five different mixing motions: ... rotating/rolling, as well as a combination ... precision-engineered moving portion of the Vibraotme ...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Adjustable tilt angle 0 to 20 Adjustable speed of 3-25 RPM Load capacity: 2.7 kg (6 lbs.) Ambient temperature range 4C to 65C Low voltage power is supplied by wall mount transformer...
Medicine Products: